{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:25:21Z","timestamp":1792160721593,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017050","name":"Cycle for Survival","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ygyno.2025.03.006","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T07:37:49Z","timestamp":1741765069000},"page":"89-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The genomic landscape of distant metastatic endometrial cancer"],"prefix":"10.1016","volume":"195","author":[{"suffix":"III","given":"William A.","family":"Zammarrelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhiksha","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Kertowidjojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea A.","family":"Moukarzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Da Cruz Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric V.","family":"Rios-Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaleigh A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Momeni-Boroujeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Makker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid K.","family":"Chatila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora H.","family":"Ellenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2025.03.006_bb0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0010","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/gyno.1994.1307","article-title":"Prognostic indicators of survival in advanced endometrial cancer","volume":"55","author":"Behbakht","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0020","series-title":"National Cancer Institute: Surveillance, Epidemiology, and End Results Program (SEER)","first-page":"2012","author":"Cancer Stat Facts - Uterine Cancer","year":"2025"},{"key":"10.1016\/j.ygyno.2025.03.006_bb0025","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2025.03.006_bb0035","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial Cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0040","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/PAS.0000000000001020","article-title":"Molecular classification of grade 3 Endometrioid endometrial cancers identifies distinct prognostic subgroups","volume":"42","author":"Bosse","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2023.05.059","article-title":"Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma","volume":"174","author":"Rios-Doria","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0050","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1158\/1078-0432.CCR-18-0412","article-title":"Clinical utility of prospective molecular characterization in advanced endometrial Cancer","volume":"24","author":"Soumerai","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0055","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1078-0432.CCR-20-4436","article-title":"Clinicopathologic and genomic analysis of TP53-mutated endometrial carcinomas","volume":"27","author":"Momeni-Boroujeni","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"563\u201375","key":"10.1016\/j.ygyno.2025.03.006_bb0060","article-title":"Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients","volume":"185","author":"Nguyen","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2025.03.006_bb0065","article-title":"Reliable Pan-Cancer microsatellite instability assessment by using targeted next-generation sequencing data","volume":"2017","author":"Middha","year":"2017","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0070","article-title":"OncoKB: a precision oncology Knowledge Base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1158\/2159-8290.CD-23-0467","article-title":"Quantifying the expanding landscape of clinical Actionability for patients with Cancer","volume":"14","author":"Suehnholz","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0080","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1158\/2159-8290.CD-22-0312","article-title":"Genetic ancestry correlates with somatic differences in a real-world clinical Cancer sequencing cohort","volume":"12","author":"Arora","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0085","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1038\/s41467-022-30453-x","article-title":"Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets","volume":"13","author":"Nacev","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0090","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1093\/bioinformatics\/btaa980","article-title":"Quantification of aneuploidy in targeted sequencing data using ASCETS","volume":"37","author":"Spurr","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ygyno.2025.03.006_bb0095","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ng.3602","article-title":"The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis","volume":"48","author":"Gibson","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2021.02.015","article-title":"Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer","volume":"161","author":"Da Cruz Paula","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/his.14346","article-title":"Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma","volume":"79","author":"Ashley","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2025.03.006_bb0110","first-page":"4","article-title":"Acquisition of APOBEC mutagenesis and microsatellite instability signatures in the development of brain metastases in low-grade, early-stage Endometrioid endometrial carcinoma","author":"Dessources","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0115","article-title":"Molecular profiling of primary endometrioid endometrial cancer and matched lung metastases: CTNNB1 mutation as a potential driver","volume":"53","author":"Gordhandas","year":"2024","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0120","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1200\/JCO.2017.73.0143","article-title":"AKT inhibition in solid tumors with AKT1 mutations","volume":"35","author":"Hyman","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0125","article-title":"A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma","volume":"40","author":"Stover","year":"2022","journal-title":"Gynecol Oncol Rep."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0130","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/modpathol.2017.15","article-title":"CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence","volume":"30","author":"Kurnit","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0135","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00428-021-03176-5","article-title":"Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma","volume":"479","author":"Ruz-Caracuel","year":"2021","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/aogs.13740","article-title":"Early-stage endometrial cancer, CTNNB1 mutations, and the relation between lymphovascular space invasion and recurrence","volume":"99","author":"Imboden","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0145","doi-asserted-by":"crossref","first-page":"1442441","DOI":"10.1155\/2022\/1442441","article-title":"The role of CTNNB1 in endometrial Cancer","volume":"2022","author":"Ledinek","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.ygyno.2025.03.006_bb0150","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/jnci\/djac119","article-title":"Genomic determinants of early recurrences in low-stage, low-grade Endometrioid endometrial carcinoma","volume":"114","author":"Safdar","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygyno.2023.10.025","article-title":"Aberrant nuclear beta-catenin distribution does not prognosticate recurrences of endometrioid endometrial cancers - a retrospective single-institutional study","volume":"179","author":"Beshar","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0160","article-title":"Brain metastases from endometrial carcinoma","volume":"2012","author":"Piura","year":"2012","journal-title":"ISRN Oncol."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1102\/1470-7330.2013.0011","article-title":"Typical and atypical metastatic sites of recurrent endometrial carcinoma","volume":"13","author":"Kurra","year":"2013","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ygyno.2025.03.006_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268794","article-title":"Prognostic features of endometrial cancer metastasis to the central nervous system","volume":"17","author":"Kuznicki","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2025.03.006_bb0175","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2013.05.010","article-title":"Bone metastases in endometrial cancer: report on 19 patients and review of the medical literature","volume":"130","author":"Uccella","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.52312\/jdrs.2023.792","article-title":"Prognostic factors in endometrial cancer patients with bone metastasis","volume":"34","author":"Ozturk Basarir","year":"2023","journal-title":"Jt Dis Relat Surg."},{"key":"10.1016\/j.ygyno.2025.03.006_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2023.100485","article-title":"Therapeutic approaches in patients with bone metastasis due to endometrial carcinoma - a systematic review","volume":"41","author":"Heidinger","year":"2023","journal-title":"J. Bone Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:21:41Z","timestamp":1777641701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825000757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":37,"alternative-id":["S0090825825000757"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.03.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The genomic landscape of distant metastatic endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}